[{"data":1,"prerenderedAt":194},["ShallowReactive",2],{"media-slots-en":3,"wiki-home-en":59,"wiki-search-pool-en":161},{"about.hero":4,"about.video":6,"about.video-cover":8,"charity.hero":10,"contact.hero":12,"footer.qr-blood":14,"footer.qr-mini":16,"footer.qr-official":18,"footer.qr-solid":20,"guide.hero":22,"home.hero":24,"home.news-featured":26,"home.story-featured":28,"news.hero":30,"news.lead":32,"news.thumb":34,"stories.cover":39,"stories.hero":46,"stories.lead":48,"wiki.cat":50,"wiki.detail-hero":55,"wiki.hero":57},[5],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fpc_banner\u002F%E5%85%B3%E4%BA%8E%E5%8D%9A%E5%8C%BB%E5%90%8C%E8%A1%8C_en.jpg?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[7],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fabout\u002F%E9%A3%9E%E4%B9%A620260729-233252_compressed.mp4",[9],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fabout\u002F%E9%A3%9E%E4%B9%A620260729-233252_frame1.jpg?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[11],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fpc_banner\u002F%E5%85%AC%E7%9B%8A%E8%B5%84%E6%BA%90%E9%93%BE%E6%8E%A5_en.jpg?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[13],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fbytx-pc-uploads\u002F2026\u002F08\u002Fbde8f2354d29ffca7dcfe395ef4711b2.jpg?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[15],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fabout\u002Fqr-blood.png?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[17],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fabout\u002Fqr-mini.png?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[19],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fabout\u002Fqr-official.png?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[21],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fabout\u002Fqr-solid.png?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[23],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fpc_banner\u002F%E7%96%BE%E7%97%85%E7%9F%A5%E8%AF%86%E5%BA%93_en.jpg?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[25],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fpc_banner\u002F%E9%A6%96%E9%A1%B5_en.jpg?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[27],"\u002Fimages\u002Fhome\u002Fnews-featured.jpg",[29],"\u002Fimages\u002Fhome\u002Fstory-featured.jpg",[31],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fpc_banner\u002F%E6%82%A3%E5%8F%8B%E5%85%B3%E6%B3%A8_en.jpg?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[33],"\u002Fimages\u002Fnews\u002Flead.jpg",[35,36,37,38],"\u002Fimages\u002Fnews\u002Fn1.jpg","\u002Fimages\u002Fnews\u002Fn2.jpg","\u002Fimages\u002Fnews\u002Fn3.jpg","\u002Fimages\u002Fnews\u002Fn4.jpg",[40,41,42,43,44,45],"\u002Fimages\u002Fstories\u002Fs1.jpg","\u002Fimages\u002Fstories\u002Fs2.jpg","\u002Fimages\u002Fstories\u002Fs3.jpg","\u002Fimages\u002Fstories\u002Fs4.jpg","\u002Fimages\u002Fstories\u002Fs5.jpg","\u002Fimages\u002Fstories\u002Fs6.jpg",[47],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fpc_banner\u002F%E6%82%A3%E8%80%85%E6%95%85%E4%BA%8B_en.jpg?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",[49],"\u002Fimages\u002Fstories\u002Flead.jpg",[51,52,53,54],"\u002Fimages\u002Fwiki\u002Fcat-1.jpg","\u002Fimages\u002Fwiki\u002Fcat-2.jpg","\u002Fimages\u002Fwiki\u002Fcat-3.jpg","\u002Fimages\u002Fwiki\u002Fcat-4.jpg",[56],"\u002Fimages\u002Fwiki\u002Fdetail-hero.jpg",[58],"https:\u002F\u002Fgaobo-byh-h5.oss-cn-beijing.aliyuncs.com\u002Fstatic\u002Fpc_banner\u002F%E6%8A%97%E7%99%8C%E7%99%BE%E7%A7%91_en.jpg?x-oss-process=image\u002Fresize,limit_1,w_1600\u002Fquality,q_80\u002Fformat,webp",{"cats":60,"current":61,"items":81},[61,66,71,76],{"slug":62,"name":63,"desc":64,"count":65},"blood","Hematologic Diseases","Learn about leukemia, lymphoma, multiple myeloma and other common blood diseases — how they present, how they are diagnosed, and what treatment options exist.",24,{"slug":67,"name":68,"desc":69,"count":70},"solid","Solid Tumors","Learn about gastric, lung, colorectal and other solid tumors, with the fundamentals and treatment-related information you need.",18,{"slug":72,"name":73,"desc":74,"count":75},"autoimmune","Autoimmune Diseases","Learn how autoimmune diseases develop, how they typically present, and how they are treated and managed.",9,{"slug":77,"name":78,"desc":79,"count":80},"technology","Treatment Technologies","Learn about CAR-T cell therapy, hematopoietic stem cell transplantation, immunotherapy and other innovative treatments.",12,[82,104,123,142],{"slug":83,"category":62,"categoryName":63,"title":84,"summary":85,"toc":86,"ymyl":87,"hasAlternate":102,"updatedAt":103},"acute-lymphoblastic-leukemia","Acute Lymphoblastic Leukemia (ALL)","Acute lymphoblastic leukemia (ALL) is a blood cancer that develops from immature lymphoid cells. It is the most common type of leukemia in children but can also occur in adults. Advances in risk stratification, targeted therapy, immunotherapy, CAR-T cell therapy, and hematopoietic stem cell transplantation (HSCT) have expanded treatment options for people with ALL.",[],{"author":88,"reviewedBy":88,"lastReviewed":88,"datePublished":88,"citations":89,"disclaimer":88},"",[90,93,96,99],{"title":91,"url":92},"National Cancer Institute (NCI). Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version. Updated May 12, 2025.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fpatient\u002Fadult-all-treatment-pdq",{"title":94,"url":95},"National Cancer Institute (NCI). Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fhp\u002Fadult-all-treatment-pdq",{"title":97,"url":98},"National Cancer Institute (NCI). Childhood Acute Lymphoblastic Leukemia (PDQ®)–Patient Version. Updated April 15, 2025.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fpatient\u002Fchild-all-treatment-pdq",{"title":100,"url":101},"National Cancer Institute (NCI). Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fhp\u002Fchild-all-treatment-pdq",false,"2026-09-14",{"slug":105,"category":62,"categoryName":63,"title":106,"summary":107,"toc":108,"ymyl":109,"hasAlternate":102,"updatedAt":103},"acute-myeloid-leukemia","Acute Myeloid Leukemia (AML)","Acute myeloid leukemia (AML) is a common type of leukemia that can occur in both children and adults. It is the most common type of acute leukemia in adults.",[],{"author":88,"reviewedBy":88,"lastReviewed":88,"datePublished":88,"citations":110,"disclaimer":88},[111,114,117,120],{"title":112,"url":113},"National Cancer Institute (NCI). Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fpatient\u002Fadult-aml-treatment-pdq ",{"title":115,"url":116},"National Cancer Institute (NCI). Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fhp\u002Fadult-aml-treatment-pdq ",{"title":118,"url":119},"National Cancer Institute (NCI). Childhood Acute Myeloid Leukemia\u002FOther Myeloid Malignancies Treatment (PDQ®)–Patient Versio","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fpatient\u002Fchild-aml-treatment-pdq ",{"title":121,"url":122},"National Cancer Institute (NCI). Childhood Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fhp\u002Fchild-aml-treatment-pdq ",{"slug":124,"category":62,"categoryName":63,"title":125,"summary":126,"toc":127,"ymyl":128,"hasAlternate":102,"updatedAt":103},"chronic-lymphocytic-leukemia","Chronic Lymphocytic Leukemia (CLL)","Chronic lymphocytic leukemia (CLL) is a type of blood cancer that usually progresses slowly and is most common in older adults. Some people with CLL may not need treatment right away and can be monitored through regular follow-up.",[],{"author":88,"reviewedBy":88,"lastReviewed":88,"datePublished":88,"citations":129,"disclaimer":88},[130,133,136,139],{"title":131,"url":132},"National Cancer Institute (NCI). Chronic Lymphocytic Leukemia Treatment (PDQ®)–Patient Version.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fpatient\u002Fcll-treatment-pdq",{"title":134,"url":135},"National Cancer Institute (NCI). Chronic Lymphocytic Leukemia Treatment (PDQ®)–Health Professional Version.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fhp\u002Fcll-treatment-pdq",{"title":137,"url":138},"American Cancer Society (ACS). Tests for Chronic Lymphocytic Leukemia (CLL).","https:\u002F\u002Fwww.cancer.org\u002Fcancer\u002Ftypes\u002Fchronic-lymphocytic-leukemia\u002Fdetection-diagnosis-staging\u002Fhow-diagnosed.html",{"title":140,"url":141},"American Cancer Society (ACS). Treating Chronic Lymphocytic Leukemia (CLL).","https:\u002F\u002Fwww.cancer.org\u002Fcancer\u002Ftypes\u002Fchronic-lymphocytic-leukemia\u002Ftreating.html",{"slug":143,"category":62,"categoryName":63,"title":144,"summary":145,"toc":146,"ymyl":147,"hasAlternate":102,"updatedAt":103},"chronic-myeloid-leukemia","Chronic Myeloid Leukemia (CML)","Chronic myeloid leukemia (CML) is a cancer of the blood and bone marrow characterized by the BCR::ABL1 fusion gene. With tyrosine kinase inhibitor (TKI) therapy, many people with CML can achieve long-term disease control.",[],{"author":88,"reviewedBy":88,"lastReviewed":88,"datePublished":88,"citations":148,"disclaimer":88},[149,152,155,158],{"title":150,"url":151},"National Cancer Institute (NCI). Chronic Myelogenous Leukemia Treatment (PDQ®)–Patient Version.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fpatient\u002Fcml-treatment-pdq",{"title":153,"url":154},"National Cancer Institute (NCI). Chronic Myelogenous Leukemia Treatment (PDQ®)–Health Professional Version.","https:\u002F\u002Fwww.cancer.gov\u002Ftypes\u002Fleukemia\u002Fhp\u002Fcml-treatment-pdq",{"title":156,"url":157},"American Cancer Society (ACS). Chronic Myeloid Leukemia (CML).","https:\u002F\u002Fwww.cancer.org\u002Fcancer\u002Ftypes\u002Fchronic-myeloid-leukemia.html",{"title":159,"url":160},"Leukemia & Lymphoma Society (LLS). Chronic Myeloid Leukemia (CML).","https:\u002F\u002Fwww.lls.org\u002Fleukemia\u002Fchronic-myeloid-leukemia",[162,170,178,186],{"slug":83,"category":62,"categoryName":63,"title":84,"summary":85,"toc":163,"ymyl":164,"hasAlternate":102,"updatedAt":103},[],{"author":88,"reviewedBy":88,"lastReviewed":88,"datePublished":88,"citations":165,"disclaimer":88},[166,167,168,169],{"title":91,"url":92},{"title":94,"url":95},{"title":97,"url":98},{"title":100,"url":101},{"slug":105,"category":62,"categoryName":63,"title":106,"summary":107,"toc":171,"ymyl":172,"hasAlternate":102,"updatedAt":103},[],{"author":88,"reviewedBy":88,"lastReviewed":88,"datePublished":88,"citations":173,"disclaimer":88},[174,175,176,177],{"title":112,"url":113},{"title":115,"url":116},{"title":118,"url":119},{"title":121,"url":122},{"slug":124,"category":62,"categoryName":63,"title":125,"summary":126,"toc":179,"ymyl":180,"hasAlternate":102,"updatedAt":103},[],{"author":88,"reviewedBy":88,"lastReviewed":88,"datePublished":88,"citations":181,"disclaimer":88},[182,183,184,185],{"title":131,"url":132},{"title":134,"url":135},{"title":137,"url":138},{"title":140,"url":141},{"slug":143,"category":62,"categoryName":63,"title":144,"summary":145,"toc":187,"ymyl":188,"hasAlternate":102,"updatedAt":103},[],{"author":88,"reviewedBy":88,"lastReviewed":88,"datePublished":88,"citations":189,"disclaimer":88},[190,191,192,193],{"title":150,"url":151},{"title":153,"url":154},{"title":156,"url":157},{"title":159,"url":160},1789384068432]